New Results
A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery
View ORCID ProfileDora Pinto, Maximilian M. Sauer, View ORCID ProfileNadine Czudnochowski, View ORCID ProfileJun Siong Low, View ORCID ProfileM. Alejandra Tortorici, Michael P. Housley, Julia Noack, View ORCID ProfileAlexandra C. Walls, John E. Bowen, View ORCID ProfileBarbara Guarino, View ORCID ProfileLaura E. Rosen, Julia di Iulio, Josipa Jerak, Hannah Kaiser, Saiful Islam, View ORCID ProfileStefano Jaconi, View ORCID ProfileNicole Sprugasci, View ORCID ProfileKatja Culap, Rana Abdelnabi, View ORCID ProfileCaroline Foo, View ORCID ProfileLotte Coelmont, View ORCID ProfileIstvan Bartha, View ORCID ProfileSiro Bianchi, Chiara Silacci-Fregni, Jessica Bassi, Roberta Marzi, View ORCID ProfileEneida Vetti, View ORCID ProfileAntonino Cassotta, View ORCID ProfileAlessandro Ceschi, View ORCID ProfilePaolo Ferrari, Pietro E. Cippà, Olivier Giannini, View ORCID ProfileSamuele Ceruti, Christian Garzoni, Agostino Riva, View ORCID ProfileFabio Benigni, View ORCID ProfileElisabetta Cameroni, View ORCID ProfileLuca Piccoli, Matteo S. Pizzuto, Megan Smithey, View ORCID ProfileDavid Hong, View ORCID ProfileAmalio Telenti, View ORCID ProfileFlorian A. Lempp, View ORCID ProfileJohan Neyts, View ORCID ProfileColin Havenar-Daughton, View ORCID ProfileAntonio Lanzavecchia, View ORCID ProfileFederica Sallusto, Gyorgy Snell, View ORCID ProfileHerbert W. Virgin, View ORCID ProfileMartina Beltramello, View ORCID ProfileDavide Corti, View ORCID ProfileDavid Veesler
doi: https://doi.org/10.1101/2021.05.09.442808
Dora Pinto
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Maximilian M. Sauer
2Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA
Nadine Czudnochowski
3Vir Biotechnology, San Francisco, CA 94158, USA
Jun Siong Low
4Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland
M. Alejandra Tortorici
2Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA
Michael P. Housley
3Vir Biotechnology, San Francisco, CA 94158, USA
Julia Noack
3Vir Biotechnology, San Francisco, CA 94158, USA
Alexandra C. Walls
2Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA
John E. Bowen
2Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA
Barbara Guarino
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Laura E. Rosen
3Vir Biotechnology, San Francisco, CA 94158, USA
Julia di Iulio
3Vir Biotechnology, San Francisco, CA 94158, USA
Josipa Jerak
4Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland
Hannah Kaiser
3Vir Biotechnology, San Francisco, CA 94158, USA
Saiful Islam
3Vir Biotechnology, San Francisco, CA 94158, USA
Stefano Jaconi
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Nicole Sprugasci
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Katja Culap
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Rana Abdelnabi
5Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, 3000 Leuven, Belgium
Caroline Foo
5Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, 3000 Leuven, Belgium
Lotte Coelmont
5Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, 3000 Leuven, Belgium
Istvan Bartha
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Siro Bianchi
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Chiara Silacci-Fregni
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Jessica Bassi
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Roberta Marzi
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Eneida Vetti
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Antonino Cassotta
4Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland
Alessandro Ceschi
6Clinical Trial Unit, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland
7Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland
8Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland
9Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland
Paolo Ferrari
9Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland
10Department of Medicine, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland
11Clinical School, University of New South Wales, 2052 Sydney, Australia
Pietro E. Cippà
10Department of Medicine, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland
12Faculty of Medicine, University of Zurich, 8057 Zurich, Switzerland
Olivier Giannini
9Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland
10Department of Medicine, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland
Samuele Ceruti
13Intensive Care Unit, Clinica Luganese Moncucco, 6900 Lugano, Switzerland
Christian Garzoni
14Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland
Agostino Riva
15III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, 20157 Milan, Italy
Fabio Benigni
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Elisabetta Cameroni
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Luca Piccoli
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Matteo S. Pizzuto
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Megan Smithey
3Vir Biotechnology, San Francisco, CA 94158, USA
David Hong
3Vir Biotechnology, San Francisco, CA 94158, USA
Amalio Telenti
3Vir Biotechnology, San Francisco, CA 94158, USA
Florian A. Lempp
3Vir Biotechnology, San Francisco, CA 94158, USA
Johan Neyts
5Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, 3000 Leuven, Belgium
Colin Havenar-Daughton
3Vir Biotechnology, San Francisco, CA 94158, USA
Antonio Lanzavecchia
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Federica Sallusto
4Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland
16Institute of Microbiology, ETH Zurich, 8093 Zurich, Switzerland
Gyorgy Snell
3Vir Biotechnology, San Francisco, CA 94158, USA
Herbert W. Virgin
3Vir Biotechnology, San Francisco, CA 94158, USA
17UT Southwestern Medical Center, Dallas, TX, 75390 USA
18Washington University School of Medicine, St. Louis, MO, 63110 USA
Martina Beltramello
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Davide Corti
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
David Veesler
2Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA
Article usage
Posted May 10, 2021.
A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery
Dora Pinto, Maximilian M. Sauer, Nadine Czudnochowski, Jun Siong Low, M. Alejandra Tortorici, Michael P. Housley, Julia Noack, Alexandra C. Walls, John E. Bowen, Barbara Guarino, Laura E. Rosen, Julia di Iulio, Josipa Jerak, Hannah Kaiser, Saiful Islam, Stefano Jaconi, Nicole Sprugasci, Katja Culap, Rana Abdelnabi, Caroline Foo, Lotte Coelmont, Istvan Bartha, Siro Bianchi, Chiara Silacci-Fregni, Jessica Bassi, Roberta Marzi, Eneida Vetti, Antonino Cassotta, Alessandro Ceschi, Paolo Ferrari, Pietro E. Cippà, Olivier Giannini, Samuele Ceruti, Christian Garzoni, Agostino Riva, Fabio Benigni, Elisabetta Cameroni, Luca Piccoli, Matteo S. Pizzuto, Megan Smithey, David Hong, Amalio Telenti, Florian A. Lempp, Johan Neyts, Colin Havenar-Daughton, Antonio Lanzavecchia, Federica Sallusto, Gyorgy Snell, Herbert W. Virgin, Martina Beltramello, Davide Corti, David Veesler
bioRxiv 2021.05.09.442808; doi: https://doi.org/10.1101/2021.05.09.442808
A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery
Dora Pinto, Maximilian M. Sauer, Nadine Czudnochowski, Jun Siong Low, M. Alejandra Tortorici, Michael P. Housley, Julia Noack, Alexandra C. Walls, John E. Bowen, Barbara Guarino, Laura E. Rosen, Julia di Iulio, Josipa Jerak, Hannah Kaiser, Saiful Islam, Stefano Jaconi, Nicole Sprugasci, Katja Culap, Rana Abdelnabi, Caroline Foo, Lotte Coelmont, Istvan Bartha, Siro Bianchi, Chiara Silacci-Fregni, Jessica Bassi, Roberta Marzi, Eneida Vetti, Antonino Cassotta, Alessandro Ceschi, Paolo Ferrari, Pietro E. Cippà, Olivier Giannini, Samuele Ceruti, Christian Garzoni, Agostino Riva, Fabio Benigni, Elisabetta Cameroni, Luca Piccoli, Matteo S. Pizzuto, Megan Smithey, David Hong, Amalio Telenti, Florian A. Lempp, Johan Neyts, Colin Havenar-Daughton, Antonio Lanzavecchia, Federica Sallusto, Gyorgy Snell, Herbert W. Virgin, Martina Beltramello, Davide Corti, David Veesler
bioRxiv 2021.05.09.442808; doi: https://doi.org/10.1101/2021.05.09.442808
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29195)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14179)
- Epidemiology (2067)
- Evolutionary Biology (18306)
- Genetics (12245)
- Genomics (16802)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60965)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)